Encompass Health Co. (NYSE:EHC) Shares Purchased by US Bancorp DE

US Bancorp DE grew its holdings in shares of Encompass Health Co. (NYSE:EHC) by 18.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,259 shares of the company’s stock after purchasing an additional 198 shares during the period. US Bancorp DE’s holdings in Encompass Health were worth $122,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the business. Janney Montgomery Scott LLC boosted its position in shares of Encompass Health by 37.4% during the 1st quarter. Janney Montgomery Scott LLC now owns 9,521 shares of the company’s stock worth $786,000 after purchasing an additional 2,592 shares in the last quarter. Envestnet Portfolio Solutions Inc. boosted its holdings in Encompass Health by 10.6% during the first quarter. Envestnet Portfolio Solutions Inc. now owns 6,410 shares of the company’s stock worth $529,000 after buying an additional 616 shares in the last quarter. QRG Capital Management Inc. grew its position in Encompass Health by 23.4% during the first quarter. QRG Capital Management Inc. now owns 7,738 shares of the company’s stock worth $639,000 after buying an additional 1,467 shares during the period. State Board of Administration of Florida Retirement System boosted its position in Encompass Health by 4.2% during the first quarter. State Board of Administration of Florida Retirement System now owns 100,216 shares of the company’s stock worth $8,276,000 after purchasing an additional 4,005 shares in the last quarter. Finally, Vanguard Group Inc. grew its stake in Encompass Health by 1.7% in the 1st quarter. Vanguard Group Inc. now owns 10,166,147 shares of the company’s stock valued at $839,520,000 after acquiring an additional 169,113 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms recently commented on EHC. Stephens reiterated an “overweight” rating and set a $105.00 price objective on shares of Encompass Health in a research report on Tuesday, August 6th. Truist Financial reaffirmed a “buy” rating and issued a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Royal Bank of Canada upped their price target on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. UBS Group raised their target price on Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, September 25th. Finally, Barclays boosted their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $107.11.

Encompass Health Price Performance

Shares of NYSE EHC opened at $98.84 on Friday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The firm has a market capitalization of $9.96 billion, a PE ratio of 23.87, a P/E/G ratio of 1.36 and a beta of 0.88. Encompass Health Co. has a 1-year low of $63.59 and a 1-year high of $104.55. The business’s fifty day moving average price is $96.38 and its two-hundred day moving average price is $90.25.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter last year, the business earned $0.86 earnings per share. Encompass Health’s revenue was up 11.9% compared to the same quarter last year. On average, research analysts expect that Encompass Health Co. will post 4.29 EPS for the current year.

Encompass Health announced that its Board of Directors has authorized a stock buyback plan on Wednesday, July 24th that permits the company to repurchase $500.00 million in shares. This repurchase authorization permits the company to reacquire up to 5.4% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a yield of 0.69%. Encompass Health’s payout ratio is 16.43%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.